Compare · 2 funds side by side · dividends reinvested

FMED and VO

FMEDFidelity×VOVanguard×

Versus in desk

02 / 04

IWD+0.0%

Search ETFs and stocks

Portfolio

Story of the two · Growth5Y$10,000 five years agoDividends reinvested · both on one scale$13,829VO · best of the two

Story of the two · IncomeMost incomeVO · 1.35% · $135 a year on $10k

Story of the two · RiskSmallest drop

FMED and VO, Ranked

Today

FundFeeYieldYTD1 year3 yrs · yr5 yrs · yrWorst dropVolatilityAssetsAvg rank

Vanguard Morningstar Mid-Cap ETFUS Stock Styles · Mid cap0.03%1.35%+13.6%+14.4%+18.0%+6.7%−8.2%13.0%$103B1.3

Fidelity Disruptive Medicine ETFThematic · Disruptive tech0.50%0.00%+22.2%+29.6%+16.3%[…]−18.3%24.9%$53M1.7

Rank among the two1st → 2ndFee, drop and volatility: lower ranks higherAvg rank: mean of the 8 ranks · 1 is best

End-of-day Nov 10, 2026 · returns include dividends · since: FMED 2020 · VO 2004

Head to Head

Swap sides Versus in desk

Head to Head

5Y

Fidelity Disruptive Medicine ETF · $53M[…]

FMED

VO

Vanguard Morningstar Mid-Cap ETF · $103B$13,829

$10,000 five years ago, dividends reinvested · they hold 0.0% in common

FMEDMeasureVO

+22.2%

More Ways to See the Pairs

FMED vs VO: Top 5 Holdings

Today

FMED

0.3%in top 5

VO

in top 55.3%

FMEDStockVO

not top 5NET1.1%

not top 5VLO1.1%

not top 5MPC1.1%

not top 5PSX1.0%

not top 5PWR1.0%

Cost, Income and Risk

Fees: FMED, VO

Today

0.03%lowest, VO

FundExpense ratioFee$10k

VO0.03%$3

FMED0.50%$50

End-of-day Nov 10, 2026 · fee on $10,000 a year

Yields: FMED, VO

1Y

1.35%highest, VO

FundTrailing yieldYield

Popular Pairs Near These Two

SCHD vs VIG

YTD

SchwabSCHD

+33.8%

VIGVanguard

+15.1%

+33.8%Year to date+15.1%

2.9%Yield1.5%

$122BAssets$109B

2–0SCHD wins

End-of-day Nov 10, 2026

JEPQ vs JEPI

YTD

J.P. MorganJEPQ

+6.0%

JEPIJ.P. Morgan

+7.6%

SPYM vs SPY

YTD

SPDRSPYM

+10.9%

SPYSPDR

+10.8%

Year to dateJan 1 → Nov 10

+13.6%

+29.6%1 yearTotal return+14.4%

+16.3%3 years · per year$10,000 became $15,750 · $16,445+18.0%

[…]5 years · per year$10,000 became […] · $13,829+6.7%

0.50%Expense ratio$50 · $3 a year on $10k · lower is better0.03%

0.00%Trailing 12-mo yield$0 · $135 a year on $10k1.35%

−18.3%Worst dropSmaller is better−8.2%

24.9%VolatilityLower is calmer13.0%

FMEDVO Winner of the row, in its colourEach row: the bigger of the two fills its side

2–5VO wins

End-of-day Nov 10, 2026 · returns include dividends · 3Y and 5Y figures are per-year returns

0.3%OMnot top 5

Held in common0.0%

End-of-day Nov 10, 2026 · share of each fund

FMED vs VO Returns, Every Period

1Y

FidelityFMED

+29.6%

past year

VOVanguard

+14.4%

past year

FMEDVOFaded: behind in that period

2–1FMED wins

End-of-day Nov 10, 2026 · dividends in · faded = behind in that period

Thematic vs Stocks: FMED vs VO

YTD

FidelityFMED

+22.2%

VOVanguard

+13.6%

+22.2%Year to date+13.6%

−18.3%Worst drop · 1Y−8.2%

24.9%Volatility · 1Y13.0%

0.0%Yield1.4%

$52.7MAssets$103B

3–1VO wins

End-of-day Nov 10, 2026 · smaller drop and lower volatility win

$10k

VO1.35%$135

FMED0.00%$0

End-of-day Nov 10, 2026 · trailing 12-month yield

Income After Fees on $10,000

1Y

$132most kept, VO

VO$135 − $3 = $132

FMED$0 − $50 = −$50

KeptFee

End-of-day Nov 10, 2026 · yield in dollars minus the fee

Overlap: FMED, VO

Today

0.0%most shared, FMED and VO

FMEDVO

FMED—0.0%

VO0.0%—

End-of-day Nov 10, 2026 · share held in common · outlined: the pair in versus

Return vs Bumpiness: 2 ETFs

1Y

+29.6%FMED, at 24.9% volatility

VOWorst drop−8.2%13.0% vol

FMEDWorst drop−18.3%24.9% vol

End-of-day Nov 10, 2026 · up and left is better

Paid More vs Made More

YTD

VOFMED

+13.6%Year to date+22.2%

1.4%Yield0.0%

+14.4%Past year+29.6%

0.03%Fee0.50%

2–2level

End-of-day Nov 10, 2026

+6.0%Year to date+7.6%

12.4%Yield7.9%

$40.7BAssets$45.2B

1–1level

End-of-day Nov 10, 2026

+10.9%Year to date+10.8%

1.0%Yield1.0%

$179BAssets$778B

1–0SPYM wins

End-of-day Nov 10, 2026

Loading…

FMED and VO

Head to Head

More Ways to See the Pairs

Cost, Income and Risk

Popular Pairs Near These Two